health news today obesity drugs glp-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Professor Receives Grant to Study

Others are located in the dorsal raphe nucleus, which produces nearly all of the serotonin used by the forebrainthe same neurotransmitter system targeted by selective serotonin reuptake inhibitors

Brussels, Belgium: 2015

Additionally, GLP-1 agonists consistently reduced the risk of visual disturbances and refractory IIH, with statistically significant effects sustained up to 24 months, demonstrating a sustained benefit throughout the treatment period

Furthermore, limited data exist regarding long-term weight maintenance, treatment discontinuation, and weight regain following cessation of therapy

It could be your general practice doctor or an internist, says Kessler

10.1016/S0140-6736(19)31149-3 46